EX-10.3 4 avxs-20170630ex103924cba.htm EX-10.3 CONFIDENTIAL TREATMENT REQUESTED License AgreementLicense Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionThis LICENSE AGREEMENT (“Agreement”) is entered into as of June 7, 2017 (“Effective Date”) by and between REGENXBIO Inc., a corporation organized under the laws of the State of Delaware, with offices at 9600 Blackwell Road, Suite 210, Rockville, MD 20850 (“Licensor”), and AveXis, Inc., a corporation organized under the laws of the State of Delaware, with offices at 2275 Half Day Road, Suite 200, Bannockburn, IL 60015. Licensor and Licensee are hereinafter referred to individually as a “Party” and collectively as the “Parties.”
CONFIDENTIAL TREATMENT REQUESTED License AgreementLicense Agreement • August 10th, 2017 • AveXis, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 10th, 2017 Company Industry JurisdictionThis LICENSE AGREEMENT (“Agreement”) is entered into as of June 7, 2017 (“Effective Date”) by and between REGENXBIO Inc., a corporation organized under the laws of the State of Delaware, with offices at 9600 Blackwell Road, Suite 210, Rockville, MD 20850 (“Licensor”), and AveXis, Inc., a corporation organized under the laws of the State of Delaware, with offices at 2275 Half Day Road, Suite 200, Bannockburn, IL 60015. Licensor and Licensee are hereinafter referred to individually as a “Party” and collectively as the “Parties.”